Real Change Starts with Real People

Reverba Global exists to bring patients and caregivers into the heart of our clients’ mission and operations, so that every story and every outcome reflects the people they serve.

Accelerating Launches.

Moving Science Forward.

Improving Lives.

Our expert team and advanced technology help our clients identify, engage, and retain the stakeholders that matter most. Across the product lifecycle, we enable more impactful, more compliant, and more human engagement. We fully understand the deep science, care pathways, and the complexities facing biopharma companies in our ever-changing industry.  

Driven by Science.

Powered by Empathy.

We’re not just storytellers. We’re problem solvers. We continuously pursue smarter solutions — integrating AI-powered tools, data-driven insights, and next-gen platforms. Yet, despite all our innovation, our biggest breakthrough is still human understanding.

With over 30 years of executive leadership experience at industry giants such as Abbott Laboratories, Amgen, Immunex, and Bristol-Myers Squibb, she has consistently spearheaded innovative strategies that reshape market dynamics.

At Abbott, she led the Immunology Division, advancing key therapies including HUMIRA into critical areas, while her strategic initiatives at Immunex and Amgen were instrumental in the breakthrough commercialization of biologics in Dermatology including Enbrel.

With extensive experience leading cross-functional teams across North America, Europe, and Asia-Pacific, Christina brings a unique ability to unify diverse groups under a cohesive vision.

Her leadership has been instrumental in navigating complex acquisitions and integrating multinational teams, fostering a culture of collaboration and innovation.

With over 25 years of operational leadership and management experience, Christina has been recognized as a PharmaVoice 100 winner for her inspiring contributions to the field. Throughout her career, she has partnered with health care companies to refine strategy, optimize structure, and accelerate growth—always with the ultimate goal of improving patient lives worldwide.

Her extensive experience equips her to lead our Customer Experience teams effectively while driving the development of our proprietary technology platforms.

His passion for customer engagement aligns seamlessly with our mission and his driven leadership helps accelerate our growth and achieve our ambitious goals. Scott brings over 20 years of experience in business development, sales, and operational leadership across a range of tech, business-to-business, and consumer industries.

He has worked for both small entities and large multinational corporations building success by utilizing great communication and common sense combined with a willingness to operate at all levels. Kern began his career as a Finance Analyst at a Fortune 100 followed by working in accounting and operations for several entrepreneurial organizations where he received hands-on experience in accounting, cash management, IT, and HR.


The Latest

  • Medical Affairs ROI: Turning Scientific Engagement Into Measurable Impact
    Medical Affairs ROI: Turning Scientific Engagement Into Measurable Impact

    Interactions led by Medical Affairs, including scientific exchange with HCPs and engagement with patients and advocacy groups, can influence clinical decisions and patient behavior, but their impact is not always…

  • Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree
    Cheryl Lubbert, CEO of Reverba Global, Named 2026 HBA Luminary Award Honoree

    Cheryl Lubbert, CEO of Reverba Global, has been named a 2026 HBA Luminary Award honoree by the Healthcare Businesswomen’s Association. The recognition reflects her leadership in advancing scientific engagement and…

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.